Alzheimer's Disease Clinical Trials

Showing 1681-1700 of 1,974 trials

Mindfulness Research Program: Designed to Enhance Wellbeing in People Living With Dementia and Their Spouses

NCT01774448

People with dementia forget things and have trouble concentrating. In addition, they and their caregivers can become depressed. This project will show whether Mindfulness-Based Cognitive Therapy (MBCT) can lessen depression, increase attention spans and improve quality of life for those affected by the disease and their caregivers. MBCT combines intensive training in mindfulness meditation with Cognitive Behavioural Therapy. Studies show the meditation component creates changes in areas of the brain associated with our ability to pay attention. This form of meditation can help those impacted by dementia become more aware of their depressive thinking, leading to improved ways of coping. The investigators predict that individuals in the early stages of dementia and their spousal caregivers will report fewer depression symptoms following the 8-week Mindfulness-Based Cognitive Therapy (MBCT) Program, as well as experience improvements in quality of life and daily mindfulness. If successful, MBCT could improve the quality of life in individuals with dementia and their caregivers, as well as may take pressure off the health care system by delaying institutionalization.

Dementia

Lakehead University36 participantsStarted Aug 2013

COMPLETEDPhase 2

Raloxifene for Women With Alzheimer's Disease

NCT00368459

This is a multisite pilot randomized trial of raloxifene or placebo for the treatment of women with Alzheimer's disease.

Alzheimer Disease

Stanford University42 participantsStarted Aug 2006

Santa Rosa, California, United States • Stanford, California, United States • Springfield, Illinois, United States +1 more locations

Mindfulness Research Program: Designed to Enhance Wellbeing in People Living With Dementia and Their Spouses

Raloxifene for Women With Alzheimer's Disease

Related Searches

Evaluating the Effectiveness of a Community Based Intervention for Persons With Dementia and Their Caregivers in a Developing Country

A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.

Ammonia Levels and Cognitive Impairment

Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's Disease

Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET Imaging

Use of Alternative Medicine in Patients With Dementia and Mild Cognitive Dysfunction

Study of Electroconvulsive Therapy (ECT) Treatment for Agitation and Aggression in Dementia

MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011)

A Safety Study of TTP4000 in Subjects With Alzheimer's Disease

Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male Subjects

An Observational Study for the Prevalence of Neuropsychiatric Symptom in Parkinson's Disease Dementia

Multi-modality MRI Study on Prediction for Mild Cognitive Impairment Conversion

Language Treatment for Progressive Aphasia

Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease

Pilot Study of the Living With Hope Program for Family Caregivers of Persons With Dementia Residing in Long Term Care

Music Therapy in Methodist Homes: a Study Investigating the Impact of a Music Therapy Programme

Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease

Physical Exercise as an Additional Treatment for Alzheimer Disease